Tag Archives: 1602/MAS/1998

Novartis-Imatinib-India case

[Business Standard] The Supreme Court will start final hearing next month on a plea by Swiss pharma firm Novartis AG challenging the order of an appellate board, which upheld the government’s denial of patent to its blood cancer drug Glivec. … Continue reading

Posted in Patent case | Tagged , , , , | 1 Comment